Counsel to Bristol-Myers Squibb in multijurisdictional class actions relating to alleged defects in certain pharmaceutical products.

Class proceeding lawsuits have been initiated in Ontario against Bristol-Myers Squibb Company, Bristol-Myers Squibb Canada, Inc., Bristol-Myers Squibb Co./La Société Bristol-Myers Squibb Canada, and Linson Pharma Inc. (BMS Defendants) and unrelated generic manufacturers of the pharmaceutical antidepressant medication, nefazodone hydrochloride, which has been linked to liver failure and other liver conditions. Class actions have also been launched in British Columbia, and Québec in relation to nefazodone hydrochloride against the BMS Defendants and Linson Pharma Co. (collectively, BMS), and unrelated generic manufacturers of nefazodone hydrochloride.